During the past decade, Sipra Labs Limited conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sipra Labs Limited" are "Pharmacokinetic Study" (2 trials). Many other conditions were trialed in "Sipra Labs Limited" in a lesser frequency.

Most popular intervention types in "Sipra Labs Limited" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Reference Product (REQUIP )" (1 trials), "Ropinirole hydrochloride CR 2mg Tablets" (1 trials) and "Test Product (Ropinirole)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sipra Labs Limited" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sipra Labs Limited". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sipra Labs Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sipra Labs Limited, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".